Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Current Assets (2018 - 2025)

TELA Bio has reported Current Assets over the past 8 years, most recently at $75.6 million for Q4 2025.

  • Quarterly results put Current Assets at $75.6 million for Q4 2025, down 3.19% from a year ago — trailing twelve months through Dec 2025 was $75.6 million (down 3.19% YoY), and the annual figure for FY2025 was $75.6 million, down 3.19%.
  • Current Assets for Q4 2025 was $75.6 million at TELA Bio, up from $56.0 million in the prior quarter.
  • Over the last five years, Current Assets for TELA hit a ceiling of $89.2 million in Q2 2023 and a floor of $44.1 million in Q3 2024.
  • Median Current Assets over the past 5 years was $64.1 million (2021), compared with a mean of $64.9 million.
  • Biggest five-year swings in Current Assets: surged 95.4% in 2023 and later plummeted 46.35% in 2024.
  • TELA Bio's Current Assets stood at $59.1 million in 2021, then rose by 5.74% to $62.4 million in 2022, then grew by 14.86% to $71.7 million in 2023, then increased by 8.85% to $78.1 million in 2024, then dropped by 3.19% to $75.6 million in 2025.
  • The last three reported values for Current Assets were $75.6 million (Q4 2025), $56.0 million (Q3 2025), and $60.7 million (Q2 2025) per Business Quant data.